CASIA OpenIR  > 中国科学院分子影像重点实验室
Liposomal Nanohybrid Cerasomes Targeted to PD-L1 Enable Dual-Modality Imaging and Improve Antitumor Treatments
Du Yang; Xiaolong Liang; Yuan Li; Ting Sun; Huadan Xue; Zhengyu Jin; Jie Tian
Source PublicationCancer Letters
2018-02-01
Issue414Pages:230-238
Abstract

Programmed death ligand-1 (PD-L1) is a central element in cancer therapies targeting immune check­points, and its expression is an important predictor of the therapeutic response. With recent approvals of therapeutic antibodies against PD-L1 and PD-1, noninvasive detection methods are now urgently needed to quantify PD-L1 expression in tumors and to evaluate the response to immune therapies. However, only few such methods are available. Thus, we fabricated nanohybrid liposomal cerasome nanoparticles loaded with the chemotherapeutic drug paclitaxel, and evaluated their value as a theranostic agent. The particles are also decorated with PD-L1 antibody to enable specic targeting, and are dual-labeled to enable near-infrared uorescence (NIRF) and magnetic resonance imaging (MRI) in vivo. Results showed that in vivo NIRF and MRI imaging following intravenous injection of cerasomes revealed a strong pos­itive contrast for tumors, indicating long-lived enhancement of relevant signals. Moreover, the cerasomes were more effective against tumors and metastasis in comparison to simultaneous but nontargeted delivery of PD-L1 antibody and paclitaxel. Taken together, the data indicate that targeted, dual-labeled cerasomes are good theranostic agents for MRI/NIRF dual-mode detection and treatment of solid tu­mors in situ.

KeywordProgrammed Cell Death Ligand-1, Near Infrared FLuorescence, Magnetic Resonance Imaging, Paclitaxel, Chemotherapy, Immunotherapy
Language英语
Document Type期刊论文
Identifierhttp://ir.ia.ac.cn/handle/173211/23177
Collection中国科学院分子影像重点实验室
Corresponding AuthorZhengyu Jin; Jie Tian
Recommended Citation
GB/T 7714
Du Yang,Xiaolong Liang,Yuan Li,et al. Liposomal Nanohybrid Cerasomes Targeted to PD-L1 Enable Dual-Modality Imaging and Improve Antitumor Treatments[J]. Cancer Letters,2018(414):230-238.
APA Du Yang.,Xiaolong Liang.,Yuan Li.,Ting Sun.,Huadan Xue.,...&Jie Tian.(2018).Liposomal Nanohybrid Cerasomes Targeted to PD-L1 Enable Dual-Modality Imaging and Improve Antitumor Treatments.Cancer Letters(414),230-238.
MLA Du Yang,et al."Liposomal Nanohybrid Cerasomes Targeted to PD-L1 Enable Dual-Modality Imaging and Improve Antitumor Treatments".Cancer Letters .414(2018):230-238.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Du Yang]'s Articles
[Xiaolong Liang]'s Articles
[Yuan Li]'s Articles
Baidu academic
Similar articles in Baidu academic
[Du Yang]'s Articles
[Xiaolong Liang]'s Articles
[Yuan Li]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Du Yang]'s Articles
[Xiaolong Liang]'s Articles
[Yuan Li]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.